SCHEMBL30468441

SCHEMBL30468441

CNS(=O)(=O)Cc1cnccn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CYP2C9 P11712 2/20 0.35
NAMPT P43490 2/20 0.35
KAT7 O95251 1/20 0.34
KAT6A Q92794 1/20 0.34
VNN1 O95497 2/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
XDH P47989 1/20 0.33
TXNRD1 Q16881 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24367867 1.00 HDAC3 (0.36) HDAC3HDAC1HDAC2HDAC6CYP2C9
SCHEMBL25541266 0.83 HDAC3 (0.37) HDAC3HDAC1HDAC2HDAC6CYP2C9
SCHEMBL21885988 0.81 ALDH1A1 (0.36) HDAC3HDAC1HDAC2HDAC6CYP2C9
SCHEMBL30437144 0.79 HSP90AA1 (0.38) HDAC3HDAC1HDAC2HDAC6CYP2C9
SCHEMBL2400031 0.79 HSP90AA1 (0.38) HDAC3HDAC1HDAC2HDAC6CYP2C9
SCHEMBL987680 0.75 HSP90AA1 (0.38) HDAC3HDAC1HDAC2HDAC6CYP2C9
SCHEMBL2400023 0.75 HDAC3 (0.36) HDAC3HDAC1HDAC2HDAC6CYP2C9
SCHEMBL21826839 0.75 HDAC3 (0.36) HDAC3HDAC1HDAC2HDAC6CYP2C9
SCHEMBL31471242 0.75 HDAC3 (0.39) HDAC3HDAC1HDAC2HDAC6CYP2C9
SCHEMBL4481303 0.75 HDAC3 (0.39) HDAC3HDAC1HDAC2HDAC6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116332910-A 2-aminopyrimidine derivatives as kinase inhibitors, preparation and use thereof 江苏威凯尔医药科技有限公司 2023-06-27 CN disclosed